Target intelligence / Profile preview

Optic atrophy 1 mitochondrial dynamin-like GTPase (OPA1)

Target
OPA1
Molecular classification
GTPase, Dynamin superfamily protein, Enzyme
01

Overview

Optic atrophy 1 mitochondrial dynamin-like GTPase (OPA1) is an inner mitochondrial membrane–anchored, large dynamin superfamily GTPase that plays a central role in mitochondrial inner membrane fusion, preserving the structure and function of cristae, maintaining respiratory chain activity, and regulating mitochondrial network morphology. OPA1 is expressed as multiple tissue-specific isoforms due to alternative splicing and proteolytic processing, producing both long (membrane-anchored) and short (soluble) forms, both of which contribute to mitochondrial fusion and cristae maintenance. Mutations in OPA1 cause autosomal dominant optic atrophy, a hereditary neurodegenerative disease, and its altered function is implicated in mitochondrial disorders and heart failure. Therapeutic modulation is complex: direct targeting is not clinically established, but the protein’s abundance and proteolytic regulation are pursued as potential strategies for neuroprotection and metabolic disease.

Other names
OPA1OPA-1Optic atrophy type 1 proteinMitochondrial dynamin-like GTPaseDynamin-related protein OPA1
02

Mechanism of action

Enhancement or inhibition of OPA1 cleavage and splicing regulates mitochondrial fusion and cristae structure, indirectly affecting cell survival and energy production. Modulating activity of upstream mitochondrial proteases (OMA1, YME1L, PARL) that process OPA1

03

Biological functions

Mitochondrial inner membrane fusionMaintenance of mitochondrial cristae morphologyRegulation of mitochondrial network organizationMaintenance of mitochondrial respiratory chain functionPrevention of cytochrome c release (apoptosis regulation)Regulation of mitochondrial membrane potentialCell survival/anti-apoptosis
04

Disease associations

Neurodegenerative disease (especially autosomal dominant optic atrophy)Cardiovascular disease (heart failure)Other mitochondrial/energy metabolism disorders
05

Safety considerations

Perturbing OPA1 function risks disrupting mitochondrial dynamics, leading to cell death, neurodegeneration, and cardiomyopathyGene therapy or protease inhibitors affecting OPA1 must balance mitochondrial fusion and fission, as excessive inhibition can cause mitochondrial fragmentation and apoptosis
06

Interacting drugs

No approved, direct small-molecule drugs currently target OPA1, but research suggests indirect interactions via mitochondrial proteases (e.g., cyclosporin A modulates OPA1 levels by blocking permeability transition pore opening)
07

Biomarkers

OPA1 protein or mRNA levels are used as a biomarker for autosomal dominant optic atrophyDetection of OPA1 mutations in clinical genetic testing for inherited optic neuropathies

Beyond the preview

Go deeper on Optic atrophy 1 mitochondrial dynamin-like GTPase (OPA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optic atrophy 1 mitochondrial dynamin-like GTPase (OPA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call